Acadia Healthcare Company, Inc.

ACHCNASDAQHealthcare● Active

$25.36

+$0.88(+3.61%)

Market Cap$2.3B

P/E Ratio—

52W High$30.2

52W Low$11.43

Avg Volume3.0M

Open$24.48

Beta0.69

Free Cash Flow Financials Revenue

Acadia Healthcare Company, Inc. (ACHC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ACHC · free cash flow · updated Jun 8, 2026

Core FCF metrics

ACHC · FCF · TTM · margin & CAGR

Free cash flow was −$439.9M for FY2025 (fiscal year ending 2025-12-31), up 21.5% year-over-year The FCF margin was -13.3%.

FY2025 Free Cash Flow−$439.9M▲ +21.5% YoY

Trailing 12M (TTM)−$291.8Mtrailing 4 quarters sum

FCF Margin-13.3%−$439.9M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ACHC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$131.9M(572M)−$439.9M▲ +21.5%-13.3%

FY2024$129.7M(690M)−$560.7M▼ 1567.5%-17.8%

FY2023$462.3M(424M)$38.2M▼ 54.7%1.3%

FY2022$380.6M(296M)$84.4M▼ 34.9%3.2%

FY2021$374.5M(245M)$129.7M▼ 70.7%5.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ACHC · P/FCF · FCF yield · FCF per share

Acadia Healthcare Company, Inc. (ACHC) reported negative free cash flow of −$0.44B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

ACHC · cash flow statement · operating / investing / financing

For FY2025, Acadia Healthcare Company, Inc. generated $131.9M in operating cash flow and spent 572M in capital expenditures, yielding −$439.9M in free cash flow.

Operating Activities

+$131.9M

Cash from core business operations

2025-12-31

Investing Activities

−$547.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$472.6M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($131.9M) − |CapEx| (572M) = FCF (−$439.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ACHC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Acadia Healthcare Company, Inc.YOU

ACHC

−$439.9M+21.5%-13.3%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Acadia Healthcare Company, Inc. (ACHC) reported free cash flow of −$439.9M for FY2025 (fiscal year ending 2025-12-31), up 21.5% year-over-year. The FCF margin was -13.3%.

Based on available data, Acadia Healthcare Company, Inc. has maintained positive free cash flow for at least 10 fiscal year(s). FCF peaked at $442.2M in FY2020.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ACHC free cash flow · 8 questions

Acadia Healthcare Company, Inc. free cash flow was −$439.9M for FY2025, up 21.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$291.8M.

ACHC free cash flowACHC FCFACHC FCF 2025ACHC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Acadia Healthcare Company, Inc. · Acadia Healthcare Company, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026